IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor

NCT05814536 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor adjusted the study strategy

Conditions

Cholangiocarcinoma With IDH1 Mutation
Solid Tumors With IDH1 Mutation

Interventions

DRUG: AB-218 capsule

Sponsor

AnHeart Therapeutics Inc.